Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biomacromolecules ; 24(11): 5230-5244, 2023 11 13.
Artículo en Inglés | MEDLINE | ID: mdl-37733485

RESUMEN

As an acute ophthalmic infection, bacterial keratitis (BK) can lead to severe visual morbidity, such as corneal perforation, intraocular infection, and permanent corneal opacity, if rapid and effective treatments are not available. In addition to eradicating pathogenic bacteria, protecting corneal tissue from oxidative damage and promoting wound healing by relieving inflammation are equally critical for the efficient treatment of BK. Besides, it is very necessary to improve the bioavailability of drugs by enhancing the ocular surface adhesion and corneal permeability. In this investigation, therefore, a synergistic antibiotic-antioxidant treatment of BK was achieved based on multifunctional block copolymer vesicles, within which ciprofloxacin (CIP) was simultaneously encapsulated during the self-assembly. Due to the phenylboronic acid residues in the corona layer, these vesicles exhibited enhanced muco-adhesion, deep corneal epithelial penetration, and bacteria-targeting, which facilitated the drug delivery to corneal bacterial infection sites. Additionally, the abundant thioether moieties in the hydrophobic membrane enabled the vesicles to both have ROS-scavenging capacity and accelerated CIP release at the inflammatory corneal tissue. In vivo experiments on a mice model demonstrated that the multifunctional polymer vesicles achieved efficient treatment of BK, owing to the enhanced corneal adhesion and penetration, bacteria targeting, ROS-triggered CIP release, and the combined antioxidant-antibiotic therapy. This synergistic strategy holds great potential in the treatment of BK and other diseases associated with bacterial infections.


Asunto(s)
Infecciones Bacterianas del Ojo , Queratitis , Animales , Ratones , Antioxidantes/farmacología , Polímeros/química , Especies Reactivas de Oxígeno , Queratitis/tratamiento farmacológico , Queratitis/microbiología , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Ciprofloxacina , Infecciones Bacterianas del Ojo/tratamiento farmacológico , Infecciones Bacterianas del Ojo/microbiología
2.
Biochem Biophys Res Commun ; 668: 62-69, 2023 08 06.
Artículo en Inglés | MEDLINE | ID: mdl-37244036

RESUMEN

This study aims to examine the impacts of Scutellaria strigillosa Hemsl. (SSH) on the proliferation, apoptosis of human hepatoma cell HepG2 and screen the bioactive components. We found that SSH extract inhibited HepG2 proliferation, arrested cell division prior to S phase. Additionally, SSH extract exposure induced apoptosis, and increased the proportions of late apoptotic cells. Specifically, we focus on the inhibitory effect of SSH extract on aspartate ß-hydroxylase, a key therapeutic target of hepatocellular carcinoma closely related with the proliferation and apoptosis of HepG2. We found SSH extract with notable inhibitory activity against aspartate ß-hydroxylase, elucidated the main bioactive constituents by HPLC-Q-TOF/MS and Molecular docking analysis. In conclusion, these results provided the antiproliferative and proapoptotic effects of SSH on HepG2 cell, elucidated the main bioactive constituents based on aspartate ß-hydroxylase inhibition. These data revealed the potential value of SSH and its bioactive components for the prevention and treatment of liver cancer for the first time.


Asunto(s)
Carcinoma Hepatocelular , Neoplasias Hepáticas , Scutellaria , Humanos , Células Hep G2 , Ácido Aspártico , Scutellaria/química , Simulación del Acoplamiento Molecular , Carcinoma Hepatocelular/patología , Neoplasias Hepáticas/patología , Proliferación Celular , Apoptosis , Oxigenasas de Función Mixta , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico
3.
ChemSusChem ; 14(7): 1659-1673, 2021 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-33565262

RESUMEN

Electrocatalytic energy conversion plays a crucial role in realizing energy storage and utilization. Clean energy technologies such as water electrolysis, fuel cells, and metal-air batteries heavily depend on a series of electrochemical redox reactions occurring on the catalysts surface. Therefore, developing efficient electrocatalysts is conducive to remarkably improved performance of these devices. Among numerous studies, transition metal-based nanomaterials (TMNs) have been considered as promising catalysts by virtue of their abundant reserves, low cost, and well-designed active sites. This Minireview is focused on the typical clean electrochemical reactions: hydrogen evolution reaction, oxygen evolution reaction, and oxygen reduction reaction. Recent efforts to optimize the external morphology and the internal electronic structure of TMNs are described, and beginning with single-component TMNs, the active sites are clarified, and strategies for exposing more active sites are discussed. The summary about multi-component TMNs demonstrates the complementary advantages of integrating functional compositions. A general introduction of single-atom TMNs is provided to deepen the understanding of the catalytic process at an atomic scale. Finally, current challenges and development trends of TMNs in clean energy devices are summarized.

4.
Carbohydr Polym ; 245: 116527, 2020 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-32718631

RESUMEN

During the process of cancer metastasis, various enzymes, cytokines, and factors were involved, and upregulated cyclooxygenase-2(COX-2) in tumor cells led to proliferation and invasion of various tumors. Many nonsteroidal anti-inflammatory drugs (NSAIDs) were used as an anticancer adjuvant in chemotherapy, such as ibuprofen (BF) and celecoxib. NSAIDs could effectively inhibit local inflammation and decreased COX-2 expression. However, most of them have serious toxicity issues due to their limit selectivity against cancer and poor water solubility. Thus hyaluronic acid-ibuprofen (HA-ss-BF), which was sensitive to the reducing environment, was prepared by binding ibuprofen (BF) to the hyaluronic acid backbone through a disulfide bond, and the HA-ss-BF polymer could self-assemble into micelles and serve as carriers to delivery doxorubicin. These redox-sensitive prodrug polymeric micelles hold multiple therapeutic advantages, including on-demand BF release and disassembling micelles responding to redox stimuli, as well as desirable cellular uptake and favorable biodistribution. These advantages indicated the redox-responsive hyaluronic acid-ibuprofen prodrug could be a promising delivery system for metastatic breast cancer treatment.


Asunto(s)
Antibióticos Antineoplásicos/administración & dosificación , Neoplasias de la Mama/tratamiento farmacológico , Doxorrubicina/administración & dosificación , Portadores de Fármacos/química , Ácido Hialurónico/química , Ibuprofeno/química , Micelas , Profármacos/química , Animales , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Disulfuros/química , Femenino , Humanos , Células MCF-7 , Ratones , Ratones Endogámicos BALB C , Células 3T3 NIH , Oxidación-Reducción , Carga Tumoral/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA